4
Changes in Ownership
IN8BIO, INC. Filed Acc 0001209191-23-058716
Chief Operating Officer acquired 12,295 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rochlin Kate Chief Operating Officer | 2023-12-13 | Grant or award | +12,295 | 17,558 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Rochlin Kate Chief Operating Officer | 2023-12-13 | Grant or award · Series A Warrants (right to buy) | +12,295 | 12,295 | D: show line 2 in the form | |||||
| Rochlin Kate Chief Operating Officer | 2023-12-13 | Grant or award · Series B Warrants (right to buy) | +12,295 | 12,295 | D: show line 3 in the form |
Loading xslF345X05/doc4.xml…